Rating Change
Barclays analysts initiated coverage on Tandem Diabetes Care, Inc. (NASDAQ:TNDM) with a rating of Equal-Weight on October 07, 2026.
new coverageNASDAQ:TNDM
Barclays Initiates Coverage on Tandem Diabetes Care, Inc. (TNDM) with Equal-Weight
Barclays analysts initiated coverage on Tandem Diabetes Care, Inc. (NASDAQ:TNDM) with a rating of Equal-Weight on October 07, 2026.
At publication ·
What changed
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) · new coverage
- Firm
- Barclays
- Rating
- Equal-Weight
- Price at event
- $15.84
- Market capitalization
- $1.4B
At a glance
Key takeaways
- Barclays initiated coverage of Tandem Diabetes Care with an Equal-Weight rating on October 7, 2026.
- TNDM stock trades at $15.84 with a $1.4B market capitalization and has gained 9.9% over the past 52 weeks.
Market Context
Tandem Diabetes Care, Inc. operates in the Healthcare sector. The stock currently trades at $15.84 with a market capitalization of $1.4B. The stock has gained 9.9% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Tandem Diabetes Care, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Tandem Diabetes Care, Inc.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 07, 2026 | Barclays | Equal-Weight | N/A |
| Sep 30, 2026 | Citigroup | Neutral | N/A |
| Sep 24, 2026 | Truist Securities | Buy | N/A |
| Aug 21, 2026 | William Blair | Outperform | N/A |
| Aug 07, 2026 | RBC Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View TNDM Stock Page
Frequently Asked Questions
What does the Equal-Weight rating mean for TNDM?
A rating of Equal-Weight from Barclays reflects the analyst's outlook on Tandem Diabetes Care, Inc. (NASDAQ:TNDM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the TNDM forecast page.